Overview

Intravenous Infusion of Lidocaine in ERCP

Status:
Unknown status
Trial end date:
2019-11-15
Target enrollment:
Participant gender:
Summary
Intravenous infusion of lidocaine significantly reduces propofol dose for ERCP and improve patients' recovery after ERCP.
Phase:
Phase 4
Details
Lead Sponsor:
Shandong University
Treatments:
Lidocaine